The board of directors of Pa Shun International Holdings Limited announced that with effect from 2 April 2024, Mr. Ma Qinghai has been appointed as chief executive officer of the Company. Mr. Ma Qinghai, aged 58, graduated from Jingdezhen Health School in Jiangxi Province with major in medicine specialist and once participated in the correspondence learning course of Traditional Chinese Medicine of Traditional Chinese Medicine and the MBA training program of Shanghai University of Finance and Economics. Mr. Ma has many years of experience in clinical medical practice, over 10 years of experiences in front-line practice of pharmaceutical marketing and over 10 years of experiences in the management in pharmaceutical enterprises.

He served in several well-known domestic pharmaceutical enterprises, and just resigned as the assistant general manager of Sinopharm Holding Xinye (Hubei) Pharmaceutical Co. Ltd. and the director of Guangji Business Division of the company. Mr. Ma is a comprehensive professional manager with extensive experience in pharmaceutical enterprise management, marketing practice and team internal training.